COVID-19 WebinarsGlobal Health

COVID-19: The Invisible Impact on Team Members

By May 19, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.

Moderator

  • Brandon Thompson
    (Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)

Faculty

  • Richard G. Fried, MD, PhD
    (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
  •  John Connors
    (CEO & President, Jan Marini Skin Research)
  •  Mark Wilkins
    (Executive Vice President and U.S. General Manager, Prollenium Medical Technologies)
  •  Aaron Burton
    (CEO, Sciton)
  •  Jenna Mons Anderson
    (CEO, AccessElite)

You May Also Like

Journal of Drugs in Dermatology JDD Article about Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024Featured ArticlesHidradenitis SuppurativaLatest NewsSkin of Color
December 3, 2025

Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024

Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Journal of Drugs in Dermatology JDD Article about Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case ReportCase ReportsFeatured ArticlesLatest News
December 1, 2025

Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report

Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok.Featured ArticlesJDD Re:ViewLatest News
November 29, 2025

JDD Re:View With Dr. Beer

Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have…

Leave a Reply